miR-506: a regulator of chemo-sensitivity through suppression of the RAD51-homologous recombination axis

Por Liu, Guoyan, Xue, Fengxia, Zhang, Wei
Publicado no Chin J Cancer (2015)

Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy

Por Wang, Yingmei, Ji, Ping, Liu, Jinsong, Broaddus, Russell R, Xue, Fengxia, Zhang, Wei
Publicado em 2009

Genomic Characterization of Gene Copy-Number Aberrations in Endometrial Carcinoma Cell Lines Derived from Endometrioid-Type Endometrial Adenocarcinoma

Por Wang, Yingmei, Yang, Da, Cogdell, David, Hu, Limei, Xue, Fengxia, Broaddus, Russell, Zhang, Wei
Publicado no Technol Cancer Res Treat (2010)

Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer

Por Liu, Guoyan, Yang, Da, Sun, Yan, Shmulevich, Ilya, Xue, Fengxia, Sood, Anil K, Zhang, Wei
Publicado em 2012

miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma

Por GUO, FEI, COGDELL, DAVID, HU, LIMEI, YANG, DA, SOOD, ANIL K., XUE, FENGXIA, ZHANG, WEI
Publicado em 2014

Copy number deletion of RAD50 as predictive marker of BRCAness and PARP inhibitor response in BRCA wild type ovarian cancer

Por Zhang, Min, Liu, Guoyan, Xue, Fengxia, Edwards, Robert, Sood, Anil K., Zhang, Wei, Yang, Da
Publicado no Gynecol Oncol (2016)

Endometrial cancer with congenital uterine anomalies: 3 case reports and a literature review

Por Gao, Jinping, Zhang, Jintian, Tian, Wenyan, Teng, Fei, Zhang, Huiying, Zhang, Xuhong, Wang, Yingmei, Xue, Fengxia
Publicado no Cancer Biol Ther (2017)

Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions

Por Guo, Fei, Parker Kerrigan, Brittany C, Yang, Da, Hu, Limei, Shmulevich, Ilya, Sood, Anil K, Xue, Fengxia, Zhang, Wei
Publicado em 2014

MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis

Por Wang, Yingmei, Hu, Limei, Ji, Ping, Teng, Fei, Tian, Wenyan, Liu, Yuexin, Cogdell, David, Liu, Jinsong, Sood, Anil K., Broaddus, Russell, Xue, Fengxia, Zhang, Wei
Publicado no J Hematol Oncol (2016)

The Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian Cancer

Por Yang, Gong, Xiao, Xue, Rosen, Daniel G., Cheng, Xi, Wu, Xiaohua, Chang, Bin, Liu, Guangzhi, Xue, Fengxia, Mercado-Uribe, Imelda, Chiao, Paul, Du, Xiang, Liu, Jinsong
Publicado em 2011

MiR-506 Suppresses Proliferation and Induces Senescence by Directly Targeting the CDK4/6-FOXM1 Axis in Ovarian Cancer

Por Liu, Guoyan, Sun, Yan, Ji, Ping, Li, Xia, Cogdell, David, Yang, Da, Parker Kerrigan, Brittany C., Shmulevich, Ilya, Chen, Kexin, Sood, Anil K., Xue, Fengxia, Zhang, Wei
Publicado em 2014

CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis

Por Yang, Gong, Rosen, Daniel G., Liu, Guangzhi, Yang, Fan, Guo, Xiaoqing, Xiao, Xue, Xue, Fengxia, Mercado-Uribe, Imelda, Huang, Jiaoti, Lin, Sue-Hwa, Mills, Gordon B., Liu, Jinsong
Publicado em 2010

Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers

Por Liu, Guoyan, Yang, Da, Rupaimoole, Rajesha, Pecot, Chad V., Sun, Yan, Mangala, Lingegowda S., Li, Xia, Ji, Ping, Cogdell, David, Hu, Limei, Wang, Yingmei, Rodriguez-Aguayo, Cristian, Lopez-Berestein, Gabriel, Shmulevich, Ilya, De Cecco, Loris, Chen, Kexin, Mezzanzanica, Delia, Xue, Fengxia, Sood, Anil K., Zhang, Wei
Publicado no J Natl Cancer Inst (2015)